April 2026 Penny Stocks With Promising Potential

The market remained flat over the last week, but it has seen a remarkable 30% increase over the past year, with earnings expected to grow by 16% annually. For those looking to invest in smaller or newer companies, penny stocks—despite their vintage name—can still offer surprising value. With solid financial foundations, these stocks have the potential to outperform while offering greater stability.

Top 10 Penny Stocks In The United States

Name Share Price Market Cap Financial Health Rating WM Technology (MAPS) $0.3738 $64.68M ★★★★★★ LexinFintech Holdings (LX) $2.14 $360.08M ★★★★★★ FinVolution Group (FINV) $4.81 $1.22B ★★★★★☆ Information Services Group (III) $3.11 $196.42M ★★★★★★ Golden Growers Cooperative (GGRO.U) $5.00 $77.45M ★★★★★★ Niagen Bioscience (NAGE) $4.93 $395.62M ★★★★★★ Village Farms International (VFF) $2.84 $326.9M ★★★★★★ SIGA Technologies (SIGA) $7.80 $327.41M ★★★★★★ BAB (BABB) $0.905 $6.57M ★★★★★★ Marine Petroleum Trust (MARP.S) $4.95 $9.9M ★★★★★☆

Click here to see the full list of 346 stocks from our US Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Identiv

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Identiv, Inc. develops, manufactures, and supplies specialty IoT products across various regions including the United States, Europe, the Middle East, and the Asia-Pacific with a market cap of approximately $104.65 million.

Operations: The company's revenue segment is the IoT Business, generating $21.48 million.

Market Cap: $104.65M

Identiv, Inc. operates in the IoT sector with a market cap of approximately US$104.65 million and is currently unprofitable with increasing losses over five years. Despite this, it has no debt and maintains a stable cash runway exceeding three years. Recent product expansions include the ID-Safe portfolio, enhancing product authentication and security across various industries. Analysts forecast revenue growth at 18.19% annually but do not expect profitability within three years. The company recently provided guidance for Q1 2026 revenue between US$6.7 million to US$7.2 million, following a full-year revenue decline in 2025 compared to the previous year.

Take a closer look at Identiv's potential here in our financial health report. Assess Identiv's future earnings estimates with our detailed growth reports.INVE Revenue & Expenses Breakdown as at Apr 2026

Sono-Tek

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Sono-Tek Corporation designs and manufactures ultrasonic coating systems for various sectors including microelectronics, alternative energy, and medical markets, with a market cap of $73.84 million.

Story Continues

Operations: The company's revenue is derived entirely from its Machinery & Industrial Equipment segment, totaling $20.42 million.

Market Cap: $73.84M

Sono-Tek Corporation, with a market cap of US$73.84 million, has shown significant earnings growth of 43% over the past year, surpassing its five-year average decline. The company is debt-free and maintains a solid financial position with short-term assets exceeding liabilities. Recent developments include a collaboration with Diamond Quanta to enhance manufacturing processes for engineered diamond applications and securing an $820,000 order for medical device coating equipment. These initiatives highlight Sono-Tek's expanding presence in the medical sector and potential for further growth through strategic partnerships and increased production capabilities.

Navigate through the intricacies of Sono-Tek with our comprehensive balance sheet health report here. Gain insights into Sono-Tek's future direction by reviewing our growth report.SOTK Debt to Equity History and Analysis as at Apr 2026

Radnostix

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Radnostix, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences both in the United States and internationally, with a market cap of $40.78 million.

Operations: Radnostix, Inc. has not reported any specific revenue segments.

Market Cap: $40.78M

Radnostix, Inc., with a market cap of US$40.78 million, is currently pre-revenue and unprofitable, facing challenges such as high volatility and a net debt to equity ratio of 116.4%. The company's short-term assets exceed its short-term liabilities but fall short of covering long-term liabilities. Despite this, Radnostix has a cash runway exceeding three years if it continues its current positive free cash flow trend. Recent events include a voluntary recall due to failed capsule specifications and reporting a net loss for 2025 compared to the previous year's slight profit, indicating operational hurdles amidst regulatory scrutiny.

Dive into the specifics of Radnostix here with our thorough balance sheet health report. Learn about Radnostix's historical performance here.INIS Revenue & Expenses Breakdown as at Apr 2026

Next Steps

Click this link to deep-dive into the 346 companies within our US Penny Stocks screener. Looking For Alternative Opportunities? We've found 14 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include INVESOTK and INIS.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments